159 related articles for article (PubMed ID: 9618736)
1. Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.
Zielińska E; Niewiarowski W; Bodalski J; Rebowski G; Skretkowicz J; Mianowska K; Sekulska M
Pharm World Sci; 1998 Jun; 20(3):123-30. PubMed ID: 9618736
[TBL] [Abstract][Full Text] [Related]
2. The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children.
Zielińska E; Niewiarowski W; Bodalski J
Eur J Clin Pharmacol; 1998; 54(9-10):779-85. PubMed ID: 9923584
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
Yang JJ; Huang CH; Liu CE; Tang HJ; Yang CJ; Lee YC; Lee KY; Tsai MS; Lin SW; Chen YH; Lu PL; Hung CC
PLoS One; 2014; 9(9):e106141. PubMed ID: 25184238
[TBL] [Abstract][Full Text] [Related]
4. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK
J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950
[TBL] [Abstract][Full Text] [Related]
5. Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.
Kagaya H; Miura M; Niioka T; Saito M; Numakura K; Habuchi T; Satoh S
Antimicrob Agents Chemother; 2012 Feb; 56(2):825-9. PubMed ID: 22106207
[TBL] [Abstract][Full Text] [Related]
6. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.
Pirmohamed M; Alfirevic A; Vilar J; Stalford A; Wilkins EG; Sim E; Park BK
Pharmacogenetics; 2000 Nov; 10(8):705-13. PubMed ID: 11186133
[TBL] [Abstract][Full Text] [Related]
8. Acetylation genotype and phenotype in patients with systemic lupus erythematosus.
Rychlik-Sych M; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Sysa-Jedrzejowska A; Skretkowicz-Szarmach K
Pharmacol Rep; 2006; 58(1):22-9. PubMed ID: 16531626
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Cascorbi I; Drakoulis N; Brockmöller J; Maurer A; Sperling K; Roots I
Am J Hum Genet; 1995 Sep; 57(3):581-92. PubMed ID: 7668286
[TBL] [Abstract][Full Text] [Related]
11. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
Bell DA; Taylor JA; Butler MA; Stephens EA; Wiest J; Brubaker LH; Kadlubar FF; Lucier GW
Carcinogenesis; 1993 Aug; 14(8):1689-92. PubMed ID: 8102597
[TBL] [Abstract][Full Text] [Related]
13. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients.
Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA
AIDS; 1994 Mar; 8(3):333-7. PubMed ID: 8031511
[TBL] [Abstract][Full Text] [Related]
14. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers.
Jarrar YB; Ismail S; Irshaid YM
Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
[TBL] [Abstract][Full Text] [Related]
16. Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
Singh N; Dubey S; Chinnaraj S; Golani A; Maitra A
Mol Diagn Ther; 2009; 13(1):49-58. PubMed ID: 19351215
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.
Chen M; Xia B; Chen B; Guo Q; Li J; Ye M; Hu Z
Can J Gastroenterol; 2007 Mar; 21(3):155-8. PubMed ID: 17377643
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
19. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital.
Oqal MK; Mustafa KN; Irshaid YM
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
